MedTrace Logo

The Role of Melanocyte in Basal Cell Carcinoma

NCT02576769 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2015-10-15

No results posted yet for this study

Summary

Basal cell carcinoma (BCC) is the most frequent neoplasia worldwide. There are more than 30 histopathologic subtypes, however the nodular subtype is the most common. Pigmented varieties are common in darker skin types, therefore in our country. Previous studies have shown an increase number and size of melanocytes. Melanogenesis were increased at the expense of hyperfunctioning melanocytes as well. The aim of the study was to describe the characteristics of melanocytes in pigmented and non-pigmented variants of basal cell carcinoma.

Conditions

Interventions

OTHER

No intervention

Sponsors & Collaborators

  • Hospital Central "Dr. Ignacio Morones Prieto"

    collaborator OTHER

  • Universidad Autonoma de San Luis Potosí

    lead OTHER

Principal Investigators

  • Juan P Castanedo-Cazares, MD, MSc · Hospital Central "Dr. Ignacio Morones Prieto"

  • Bertha Torres-Alvarez, MD · Hospital Central "Dr. Ignacio Morones Prieto"

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-11-30
Completion
2016-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02576769 on ClinicalTrials.gov